Insulin glargine's main metabolic effect as metabolite M1
(HealthDay)—For patients with type 2 diabetes, following administration of a subcutaneous injection of a therapeutic dose of insulin glargine, glargine is minimally detectable in blood, and most of the plasma insulin concentration ...
Oct 25, 2012
0
0